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• Heart disease is the leading cause of death in the U.S. 
with aortic stenosis (AS) being present in 1.5 million 
Americans, and severe symptomatic AS affecting 
250,000 Americans1.
• Transcatheter Aortic Valve Replacement (TAVR) 
surgery is a minimally invasive procedure which 
replaces the aortic valve in the heart using a porcine 
valve attached to a catheter2.
• TAVR is the preferred procedure for patients suffering 
from aortic stenosis who are high risk patients for 
surgical aortic valve replacement (SAVR)3,4.
Year 2012 2013 2014 2015 2016 2017
Total Patients 13 71 83 105 173 134 579
1 Year 
Mortality
2 9 9 11 21 12 64
Relative 
Frequency
15.38% 12.68% 10.84% 10.48% 12.14% 8.96% 11.05%
• Patients who underwent the TAVR procedure at LVHN 
had a year mortality of 11.05% (CI 95%, 8.50%-
13.60%).
• 8.29% (CI 95%, 6.04%-10.54%) of patients 
experienced procedural complications.
• New onset stroke and (LBBB) were present in 3.80% 
(95% CI, 2.24%-5.36%) and 12.95% (95% CI, 10.22%-
15.68%) of all patients.
• The relative frequency of patients that experienced 
procedural complications and then died within one 
year of TAVR was significantly higher than for patients 
that died within one year, but did not experience 
complications (p < 0.05).
This study analyzes 1-year mortality as well as clinical 
outcomes and procedural complications of patients who 
underwent TAVR surgery in the Lehigh Valley Health 
Network between 2012-2017. 
• LVHN 1-year mortality frequencies were significantly 
lower than published values5.
• Stroke and LBBB rates at discharge are comparable to 
published values5,6.
• Procedural complications for patients during TAVR are 
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• Methods
• A retrospective review of all TAVR patients was 
recorded from 2012-2017 at the Lehigh Valley Health 
Network. 
•This study included 624 patients. Using the EPIC database, 
electronic hospital records of all patients were reviewed 
and organized into an Excel file.
• The variables that were tested included 7 procedural 
complications, 2 common outcomes present at 
discharge, and 1-year mortality rates.
• Due to lack of patient information available on Epic, 
only 579 patients were used in the final analysis.
Figure 1: 1-year mortality frequencies of patients following TAVR procedure between 2012-2017 at Lehigh Valley Health Network 
(LVHN). 1-year mortality frequencies are not statistically different between 2012-2017 (p < .05). LVHN 1-year mortality following 
TAVR was estimated at 11.05% (CI 95%, 8.50%-13.60%), while national published values indicate a 23.7% 1-year mortality5. LVHN 

















Figure 2: Relative distribution of procedural complications (n = 48) during TAVR. 8.29% (CI 95%, 6.04%-10.54%) of patients who 






























Figure 3: Indication of stroke and left bundle branch block (LBBB) at discharge. Comparisons of relative frequencies for both 
outcomes between LVHN and published values5,6. There is no statistical difference between LVHN and published values for either 
new onset stroke or LBBB at discharge (p > 0.05). 
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Figure 5: Relative frequencies of 1-year mortalities for patients that either experienced a certain outcome/complication 
and for those that did not. Complications, stroke at discharge, and new onset LBBB were all evaluated for 1-year 
mortality. Only patients who experience procedural complications had a significantly higher 1-year mortality from 
patients that did not experience complications (p < 0.05).
